Order: Francis Esteban Matos: Final Debarment
FDA issued a final debarment order against Francis Esteban Matos, permanently prohibiting him from providing services to any drug manufacturer. This does not directly change regulatory requirements for businesses but serves as a compliance reminder regarding debarment checks.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 23, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. All drug manufacturers (branded, generic, API, contract, compounding) should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately, but no specific deadline; ongoing compliance obligation.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
A specific individual has been added to the FDA debarment list.
Who it affects
All drug manufacturers (branded, generic, API, contract, compounding)
What you must do
Verify that Francis Esteban Matos is not currently employed or contracted in any capacity related to drug manufacturing.
Deadline
Immediately, but no specific deadline; ongoing compliance obligation.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA revises compliance guide on pre-approval inspections - RAPS
- FDA Issues Guidance on Alternative Tools for Assessing Drug Manufacturing Facilities in Pending Applications - ArentFox Schiff
- Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans - ArentFox Schiff
- Revocation of the Color Additive Listing for Use of Orange B on Casings or Surfaces of Frankfurters and Sausages
- Proposal to Revoke the Color Additive Listing for Use of Citrus Red No. 2 on the Skins of Mature Oranges